Literature DB >> 22982637

Debilitating progressive encephalitis in a patient with BTK deficiency.

Iraj Mohammadzadeh1, Mehdi Yeganeh, Mojdeh Khaledi, Mohammad Reza Salehiomran, Asghar Aghamohammadi, Nima Rezaei.   

Abstract

X-linked agammaglobulinemia (XLA), also known as Bruton's tyrosine kinase (BTK) deficiency, is a primary antibody deficiency, characterized by low number of B cells, agammaglobulinemia and increased susceptibility to a variety of infections. Herein, we report a case of XLA with confirmed BTK mutation that developed neurological deficits. While we could not detect any responsible microorganism in spite of comprehensive workup, brain magnetic resonance imaging revealed moderate brain atrophy. The diagnosis of progressive encephalitis was made for this patient. Patients with XLA have a higher chance of encephalitis compared with other primary antibody deficiencies. Given the violent nature of encephalitis, it is a concern among XLA patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22982637     DOI: 10.1556/AMicr.59.2012.3.4

Source DB:  PubMed          Journal:  Acta Microbiol Immunol Hung        ISSN: 1217-8950            Impact factor:   2.048


  2 in total

1.  BTK gene targeting by homologous recombination using a helper-dependent adenovirus/adeno-associated virus hybrid vector.

Authors:  H Yamamoto; M Ishimura; M Ochiai; H Takada; K Kusuhara; Y Nakatsu; T Tsuzuki; K Mitani; T Hara
Journal:  Gene Ther       Date:  2015-08-17       Impact factor: 5.250

Review 2.  X-linked Agammaglobulinemia.

Authors:  Deepti Suri; Amit Rawat; Surjit Singh
Journal:  Indian J Pediatr       Date:  2016-02-24       Impact factor: 5.319

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.